Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:41
作者
Nier, Anika [1 ]
Huber, Yvonne [2 ]
Labenz, Christian [2 ]
Michel, Maurice [2 ]
Bergheim, Ina [1 ]
Schattenberg, Joern M. [2 ]
机构
[1] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, A-1090 Vienna, Austria
[2] Johannes Gutenberg Univ Mainz, Dept Med 1, Metab Liver Res Program, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
non-alcoholic fatty liver disease; dietary fiber consumption; bacterial endotoxin; hepatic fibrosis; GUT MICROBIOTA; FIBROSIS; STEATOHEPATITIS; PATHOGENESIS; IMPACT; RISK;
D O I
10.3390/nu12030699
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
(1) Background: The etiology of non-alcoholic fatty liver disease (NAFLD) is multifactorial. Dietary composition has been implicated as a factor modulating intestinal barrier and could affect disease severity. The aim of this study was to evaluate dietary intake and markers of intestinal permeability in patients with NAFLD. (2) Methods: We enrolled 63 patients with NAFLD and compared them to age-matched controls. (3) Results: body mass index (BMI) and leptin to adiponectin ratio-the latter being an indicator of abdominal fat accumulation-correlated with the degree of hepatic steatosis being accompanied with rising levels of fasting insulin. Furthermore, endotoxin plasma levels and markers of inflammation were significantly higher in NAFLD compared to controls and increased with the severity of hepatic steatosis. Despite comparable intake of total energy and macronutrients, intake of fiber was lower in all patients with NAFLD compared to controls and were negatively related to disease severity. (4) Conclusions: Taken together, results of the present study suggest that fiber intake in patients is negatively related to steatosis degree and bacterial endotoxin levels, further suggesting that dietary fiber intake may be a target in NAFLD treatment (NCT: 02366052 and 03482284).
引用
收藏
页数:11
相关论文
共 36 条
  • [1] The burden of liver disease in Europe: A review of available epidemiological data
    Blachier, Martin
    Leleu, Henri
    Peck-Radosavljevic, Markus
    Valla, Dominique-Charles
    Roudot-Thoraval, Francoise
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 593 - 608
  • [2] Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy
    Chan, Ruth
    Wong, Vincent Wai-Sun
    Chu, Winnie Chiu-Wing
    Wong, Grace Lai-Hung
    Li, Liz Sin
    Leung, Jason
    Chim, Angel Mei-Ling
    Yeung, David Ka-Wai
    Sea, Mandy Man-Mei
    Woo, Jean
    Chan, Francis Ka-Leung
    Chan, Henry Lik-Yuen
    [J]. PLOS ONE, 2015, 10 (09):
  • [3] Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
    Chang, Yoosoo
    Jung, Hyun-Suk
    Yun, Kyung Eun
    Cho, Juhee
    Cho, Yong Kyun
    Ryu, Seungho
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (12) : 1861 - 1868
  • [4] The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs
    Cook, Nigel
    Geier, Andreas
    Schmid, Andreas
    Hirschfield, Gideon
    Kautz, Achim
    Schattenberg, Jorn M.
    Balp, Maria-Magdalena
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [5] Dietary intervention impact on gut microbial gene richness
    Cotillard, Aurelie
    Kennedy, Sean P.
    Kong, Ling Chun
    Prifti, Edi
    Pons, Nicolas
    Le Chatelier, Emmanuelle
    Almeida, Mathieu
    Quinquis, Benoit
    Levenez, Florence
    Galleron, Nathalie
    Gougis, Sophie
    Rizkalla, Salwa
    Batto, Jean-Michel
    Renault, Pierre
    Dore, Joel
    Zucker, Jean-Daniel
    Clement, Karine
    Ehrlich, Stanislav Dusko
    [J]. NATURE, 2013, 500 (7464) : 585 - +
  • [6] Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
    Dulai, Parambir S.
    Singh, Siddharth
    Patel, Janki
    Soni, Meera
    Prokop, Larry J.
    Younossi, Zobair
    Sebastiani, Giada
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Stal, Per
    Wong, Vincent Wai-Sun
    Kechagias, Stergios
    Hultcrantz, Rolf
    Loomba, Rohit
    [J]. HEPATOLOGY, 2017, 65 (05) : 1557 - 1565
  • [7] EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
    European Association for the Study of the Liver
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1121 - 1140
  • [8] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Estes, Chris
    Razavi, Homie
    Loomba, Rohit
    Younossi, Zobair
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 123 - 133
  • [9] Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
    Giorgio, Valentina
    Miele, Luca
    Principessa, Luigi
    Ferretti, Francesca
    Villa, Maria Pia
    Negro, Valentina
    Grieco, Antonio
    Alisi, Anna
    Nobili, Valerio
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 (06) : 556 - 560
  • [10] The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation
    Hamaguchi, Masahide
    Kojima, Takao
    Itoh, Yoshito
    Harano, Yuichi
    Fujii, Kota
    Nakajima, Tomoaki
    Kato, Takahiro
    Takeda, Noriyuki
    Okuda, Junichi
    Ida, Kazunori
    Kawahito, Yutaka
    Yoshikawa, Toshikazu
    Okanoue, Takeshi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (12) : 2708 - 2715